Funding period: 2012 - 2012
Completed
T Siegal, H Charbit, I Paldor, B Zelikovitch, T Canello, A Benis, ML Wong, AP Morokoff, AH Kaye, I Lavon
2016-10-01
Objective: Bevacizumab is an antiangiogenic agent under investigation for use in patients with high-grade glioma. It produces a hi..
Z Areeb, SS Stylli, R Koldej, DS Ritchie, T Siegal, AP Morokoff, AH Kaye, RB Luwor
2015-11-01
Glioblastoma is the most aggressive and lethal tumour of the central nervous system and as such the identification of reliable pro..
IE Bennett, H Guo, N Kountouri, GM D'Abaco, CM Hovens, BA Moffat, P Desmond, K Drummond, AH Kaye, AP Morokoff
We investigated the correlation between the circulating and imaging biomarkers of tumour vascularity, and examined whether they ar..